CIK 0001743881
- Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,117,307
- in 3 filings, $5.1M under 10b5-1 plans
Net −$5,117,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-07-01 | SCHELLER RICHARD H Director | Exercise or conversion · Common Units | −19,318 | 0 | ||
| 2019-07-01 | SCHELLER RICHARD H Director | Exercise or conversion · Management Incentive Units | −59,381 | 0 | ||
| 2019-07-01 | SCHELLER RICHARD H Director | Exercise or conversion · Management Incentive Units | −42,100 | 0 | ||
| 2019-07-01 | SCHELLER RICHARD H Director | Exercise or conversion · Management Incentive Units | −35,742 | 0 | ||
| 2019-07-01 | Sinha Uma Chief Scientific Officer | Purchase | +14,000 | $17.00 | $238K | 14,000 |
| 2019-07-01 | MCCORMICK FRANK Chairman of Oncology | Exercise or conversion | +47,165 | 47,165 | ||
| 2019-07-01 | MCCORMICK FRANK Chairman of Oncology | Exercise or conversion | +132,317 | 179,482 | ||
| 2019-07-01 | MCCORMICK FRANK Chairman of Oncology | Exercise or conversion | +66,729 | 246,211 | ||
| 2019-07-01 | MCCORMICK FRANK Chairman of Oncology | Exercise or conversion | +406,723 | 652,934 | ||
| 2019-07-01 | MCCORMICK FRANK Chairman of Oncology | Exercise or conversion | +418,016 | 1,070,950 | ||
| 2019-07-01 | MCCORMICK FRANK Chairman of Oncology | Exercise or conversion | +290,476 | 1,361,426 | ||
| 2019-07-01 | MCCORMICK FRANK Chairman of Oncology | Exercise or conversion · Common Units | −47,165 | 0 | ||
| 2019-07-01 | MCCORMICK FRANK Chairman of Oncology | Exercise or conversion · Common Units | −132,317 | 0 | ||
| 2019-07-01 | MCCORMICK FRANK Chairman of Oncology | Exercise or conversion · Series B Units | −66,729 | 0 | ||
| 2019-07-01 | MCCORMICK FRANK Chairman of Oncology | Exercise or conversion · Management Incentive Units | −406,723 | 0 | ||
| 2019-07-01 | MCCORMICK FRANK Chairman of Oncology | Exercise or conversion · Management Incentive Units | −418,016 | 0 | ||
| 2019-07-01 | MCCORMICK FRANK Chairman of Oncology | Exercise or conversion · Management Incentive Units | −290,476 | 0 | ||
| 2019-07-01 | HENDERSON MICHAEL THOMAS | Exercise or conversion | +8,420 | 8,420 | ||
| 2019-07-01 | HENDERSON MICHAEL THOMAS | Exercise or conversion | +8,420 | 16,840 | ||
| 2019-07-01 | HENDERSON MICHAEL THOMAS | Exercise or conversion | +151,563 | 168,403 |
Page 58 of 61 · 1,201 trades